• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Egg Allergy Market

    ID: MRFR/Pharma/3312-CR
    85 Pages
    Rahul Gotadki
    June 2024

    Egg Allergy Market Research Report Information by Age Group (Children and Adults), Diagnosis & Treatment (Diagnosis [Skin Test, Blood Test, Food Challenge and others] and Treatment [Medication and Oral Immunotherapy]), End User (Hospitals and Clinics, Diagnostic Centers, Research Institutes and others) - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Egg Allergy Market Infographic
    Purchase Options

    Egg Allergy Market Summary

    The Global Egg Allergy Market is projected to grow from 1.48 USD Billion in 2024 to 2.81 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Global Egg Allergy Key Trends and Highlights

    • The market is expected to expand at a compound annual growth rate (CAGR) of 6.0 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 2.81 USD Billion, indicating a substantial increase from the base year.
    • In 2024, the market is valued at 1.48 USD Billion, laying a strong foundation for future growth.
    • Growing adoption of allergen-free food products due to rising awareness of food allergies is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.48 (USD Billion)
    2035 Market Size 2.81 (USD Billion)
    CAGR (2025-2035) 6.0%

    Major Players

    Genentech, Inc. (the US), Sanofi SA (France), ImmuneTech (US), Quest Diagnostics (US), HYCOR Biomedical (US), Alletess Medical Laboratory (US), Kaleo, Inc. (the US), Imutest Ltd (UK), Creative Diagnostics (US), Impax Laboratories (US), Mylan NV (US)

    Egg Allergy Market Trends

    Major drivers of the market

    The egg allergy market size is evolving at a faster pace, and in the upcoming times, it will grow immensely. The number of cases of egg allergies is increasing day by day, both in adults as well as infants. Most number of cases over the years has happened to children more than egg allergy in adults. Symptoms of egg allergy in children outgrow way before it results in egg allergy symptoms in adults. The food allergy prevalence has increased to a greater extent which acts as a driving force for the growth of the global egg allergy market.

    Several technological advancements in egg allergy medication and treatment resulted in propelling the egg allergy market size. 

    The technological advancements in egg allergy treatment and diagnosis methods include skin prick test, food challenge, blood test, oral immunotherapy, and many more. These advanced methods of treatment increase the skin allergy test market size and help to propagate the growth of the egg allergy market to the optimum level in the forecast period.

    Significant growth opportunities for the market

    The egg allergy market is increasing to greater heights in a short time span, and the market will continue to grow in the future due to an extreme increase in egg allergy cases. The skin allergy test market size is rising exponentially with the advanced technological methods of diagnosis and treatment. These advancements are not just limited to egg allergy treatment but also include advancements in the identification process and screening. Various food scanners, apps, portable devices, and wearable are helpful in determining different food ingredients related to egg allergy.

    These devices are major opportunities for increasing the egg allergy industry size in the upcoming years.

    Market restraints

    The global egg allergy market is definitely growing at a faster rate, but the market growth can be hindered due to a lack of awareness among patients. The developing countries tend to avoid allergies, and the reason behind it lacks awareness. Many patients overlook the allergies and do not take any egg allergy treatment on time. The egg allergy cases in these countries are comparatively low, and the poor healthcare sector is also responsible for the same. Another prime restraint for the egg allergy industry is the hefty cost involved in the diagnosis and treatment process.

    Many tests are also not covered by any insurance policies. Such constraints restrict the growth of the egg allergy market size.

    Market Growth Challenges

    The egg allergy market is immensely dependent on the number of cases of egg allergy patients. Many patients overlook and avoid egg allergy medication in time which leads to declining market growth. Various tests like radioallergosorbent test (RAST) and enzyme-linked immunosorbent assay (ELISA or EIA) has their own limitations, which sometimes show false results and diagnosis failure due to cross-contamination. These testing procedures also require proficient egg allergy industry therapeutics who can handle the tests properly, which hinders the market growth of the egg allergy market size.

    Value Chain Analysis

    The revenue of the egg allergy industry is continuously escalating over the years and will continue to grow in the forecast years. Various egg research and consultancy sectors are focusing on the prevention and cure of the disease. The continuous effort for producing better egg allergy medication has resulted in the increasing the market value of the egg allergy market. The expansion of skin allergy test market size will reach greater levels in the upcoming years.

    The prevalence of egg allergy among children appears to be on the rise, necessitating increased awareness and management strategies to address this growing public health concern.

    Centers for Disease Control and Prevention (CDC)

    Egg Allergy Market Drivers

    Rising Prevalence of Egg Allergy

    The increasing incidence of egg allergy, particularly among children, is a primary driver of the Global Global Egg Allergy Market Industry. Studies indicate that egg allergy affects approximately 1.5 to 2.5 percent of children globally, with many outgrowing it by adolescence. However, the persistent cases contribute to a growing demand for allergen-free products. As awareness of food allergies rises, parents and caregivers are more vigilant, leading to increased consumption of egg-free alternatives. This trend is expected to propel the market, with projections estimating the market value to reach 1.48 USD Billion in 2024.

    Market Segment Insights

    Egg Allergy Age Group Insights

    The egg allergy industry size segmentation on the basis of age group includes children and adults. The egg allergy symptoms in adults are very less compared to children, so the children have the largest share in the egg allergy industry. 

    Egg Allergy Treatment Insights

    The treatment segment consists of sub-segments that include egg allergy medication and oral immunotherapy process, whereas the diagnosis segment consists of tests like blood tests, skin tests, and others.

    Egg Allergy end-user Insights

    Egg allergy market segmentation on the basis of end-user comprises hospitals and clinics, egg research and consultancy, and diagnostics centers. 

    Get more detailed insights about Egg Allergy Market by Share, Size, Growth and Overview – 2030

    Key Companies in the Egg Allergy Market market include

    Future Outlook

    Egg Allergy Market Future Outlook

    The Global Egg Allergy Market is projected to grow at a 6.0% CAGR from 2024 to 2035, driven by rising awareness, innovative treatments, and increasing prevalence of allergies.

    New opportunities lie in:

    • Develop personalized dietary solutions for egg allergy patients.
    • Invest in research for novel immunotherapy treatments.
    • Expand product lines to include egg-free alternatives in mainstream markets.

    By 2035, the market is expected to demonstrate robust growth, reflecting heightened consumer demand and innovative solutions.

    Report Scope

    Attribute/Metric Details
    Market Size USD 2.01643 Billion by 2030
    CAGR 6.90% (2022-2030)
    Base Year   2021
    Forecast Period   2022-2030
    Historical Data   2020
    Forecast Units   Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Types, end user, Region
    Geographies Covered America, Europe, Asia Pacific, Middle East and Africa
    Key Vendors Genentech Inc. (the US), Sanofi SA (France), ImmuneTech (US), Quest Diagnostics (US), HYCOR Biomedical (US), Alletess Medical Laboratory (US), Kaleo Inc. (the US), Imutest Ltd (UK), Creative Diagnostics (US), Impax Laboratories (US), Mylan NV (US)

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    At what CAGR is the global egg allergy market projected to grow in the forecast period (2024-2032)?

    Egg allergy market projected to grow at approximately 6.90% CAGR during the assessment period (2022-2030).

    How much is the global egg allergy market worth in the future?

    The valuation of the global egg allergy market is estimated to increase to USD 2.016 Billion by the end of 2030

    What are the major tailwinds pushing the growth of the global egg allergy market?

    Increasing prevalence, improved allergy diagnosis, and rising healthcare expenses are major tailwinds pushing the growth of the global egg allergy market.

    Which region holds the largest share in the global egg allergy market?

    North America holds the largest share in the global egg allergy market, followed by Europe and the Asia Pacific, respectively.

    Who are the top players in the global egg allergy market?

    Genetech, Inc. (US), Mylan N.V. (US), Sanofi (France), Alletess Medical Laboratory (US), Creative Diagnostics (US), HYCOR Biomedical (US), Impax Laboratories, Inc. (US), Kaleo, Inc. (US), Kaleo, Inc. (US), Impax Laboratories (US), Quest Diagnostics (US), ImmuneTech (US), and Imutest Ltd. (UK), are some of the top players operating in the global egg allergy market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials